Karo Bio AB is acquiring the American biotechnology company Novalon Pharmaceutical Corporation based in Durham, North Carolina through a non- cash issue. “The acquisition of Novalon will strengthen Karo Bio’s technology base for the development of new drug substances that act upon nuclear receptors, which will make it possible to start several new projects and Read more about Karo Bio To Acquire Novalon[…]